The Global Hematological Cancer Therapeutics Market to Surpass USD 100 Billion by 2027 | DelveInsight
08 nov. 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The Global Hematological Cancer Therapeutics Market to Surpass USD 100 Billion by 2027 | DelveInsight The hematological cancer therapeutics market...
Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group
03 nov. 2021 10h00 HE
|
Lynx Biosciences, Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Lynx Biosciences, Inc. ("LynxBio®"), a San Diego-based biotechnology company, today announced the successful closing of its Series Seed Preferred Stock...